MITO

Stealth BioTherapeutics Corp. ADS

Delisted

MITO was delisted on the 15th of November, 2022.

15 hedge funds and large institutions have $607K invested in Stealth BioTherapeutics Corp. ADS in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
IC
1
Ikarian Capital
Texas
$397K
Renaissance Technologies
2
Renaissance Technologies
New York
$48K -$8.24K -9,827 -15%
BFM
3
Boothbay Fund Management
New York
$40K
Millennium Management
4
Millennium Management
New York
$33K +$3.46K +4,198 +12%
Two Sigma Advisers
5
Two Sigma Advisers
New York
$21K -$167 -200 -0.8%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$19K -$966 -1,185 -5%
GSC
7
Ground Swell Capital
South Carolina
$16K +$16K +18,927 New
Citadel Advisors
8
Citadel Advisors
Florida
$13K +$13K +16,213 New
Envestnet Asset Management
9
Envestnet Asset Management
Illinois
$10K +$10K +12,417 New
Morgan Stanley
10
Morgan Stanley
New York
$4K -$800 -1,000 -17%
Osaic Holdings
11
Osaic Holdings
Arizona
$4K +$1.83K +2,314 +84%
AA
12
AlphaMark Advisors
Kentucky
$2K
BBHC
13
Brown Brothers Harriman & Co
New York
$145
HF
14
HRT Financial
New York
-$26K -19,835 Closed
SBL
15
Sargent Bickham Lagudis
Colorado
-$20K -14,714 Closed